Resource Centers
- Adolescent Medicine
- Adverse Drug Events Reporting
- Cardiovascular Health Management in a Multicultural Society
- Electronic Health Records
- Geriatric Care
- Healthcare Reform
- Health Diversity
- Hyperlipidemia
- Hypertension
- Immunization
- Integrative Medicine
- Obesity and Weight Management
- Pain Management: Pharmacologic Approaches
- More »
- Low White Blood Cell Count Distinguishes Lyme Arthritis From Septic Arthritis
- Older Women With Visual Field Loss Have Higher Risk for Fractures
- High Prevalence of Masked Hypertension in Children With Kidney Disease
- Longer Second-Stage Labor Is Worse for Mothers Than for Newborns
- Alert FDA Recalls Synthes USA Vertebral Body Replacement
Family Medicine Journals
Medscape Community Resources
Related Blogs
- Friday night in Orlando
- Old experienced MD vs young well-read MD: Who's your doc?
- The drospirenone Debate
- Baseline PSA at Age 40 Reinforced by AUA: What Happened to Evidence Based Medicine?
- Busted
- Sponsored Blog
- Post-Hoc Analysis
POLL
In a BMJ editorial published last month, mandatory screening of all electively admitted patients for MRSA in UK hospitals was criticized for being "unethical" and "unjustified," citing it as potentially harmful because of a potential delay in treatment. Do you favor or oppose mandatory screening for MRSA in hospitalized patients?
- Sponsored Blog
- Post-Hoc Analysis
- A Treatment Option for Atrial Fibrillation
- A single medication with 4 indications
- ABILIFY® (aripiprazole)
- ADHD treatment: Efficacy, insights, and dosing
- AMBIEN CR® (zolpidem tartrate extended-release CIV)
- Atrial Fibrillation Condition Site
- CRESTOR® (rosuvastatin calcium)
- Carac® (fluorouracil cream 0.5%)
- Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension
- Clinical Management Center
- DanActive® and ACTIVIA® Information Center
- Diabetes in America
- ENABLEX® (darifenacin) Extended-Release Tablets 7.5 mg or 15 mg
- Epilepsy360: Connections in Care
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- GEODON® (ziprasidone HCI)
- IL-6 and Rheumatoid Arthritis
- Institute for Advances in Point-of-Care Testing
- LEVAQUIN® (levofloxacin) tablets/injection
- LOVAZA® (omega-3-acid ethyl esters)
- NUCYNTA (tapentadol)
- Navigenics® Genetic Risk Assessment Services
- Neuroendocrine tumors: Increasing in incidence and easy to overlook
- OPTIMAL Forum"
- Onglyza" (saxagliptin) InfoSite
- PREMARIN® (conjugated estrogens tablets, USP)
- PRISTIQ® (desvenlafaxine)
- ProAir® HFA
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- QuickVue® Influenza A+B Test
- REBIF® (interferon beta-1a)
- Reclast® (zoledronic acid) injection
- Risk of Osteoporosis
- SANDOSTATIN® LAR DEPOT (octreotide acetate for injectable suspension)
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- TOVIAZ® (fesoterodine fumarate)
- The Pain Institute
- VESIcare (solifenacin succinate) tablets
- VIGAMOX® solution
- Vyvanse (lisdexamfetamine dimesylate)
- XYZAL® (levocetirizine dihydrochloride)
Latest from The Medical Home at
Medscape.com/PCMH
Medscape.com/PCMH
Advisory Board
- Bradley Fox, MD
- Valerie Gilchrist, MD
- Alicia Hart, MD
- Desiree Lie, MD, MSEd
- Robert Morrow, MD
- Dennis Salisbury, MD
- Charles Vega, MD
Site Editorial Director